H.R. 3: The “No New Cures Ever” Act
In the coming weeks, Speaker Nancy Pelosi’s (D-Calif.) priority drug pricing bill, H.R. 3, is expected to come up for a vote in the House of Representatives. Make no…
Tony Gonzales (R-TX-23) 16.7% / 54.3%
Maxine Waters (D-CA-43) 75% / 13%
Chip Roy (R-TX-21) 83.3% / 95.7%
Brad Sherman (D-CA-32) 58.3% / 12.3%
Wesley Hunt (R-TX-38) 83.3% / 87.1%
Susan Wild (D-PA-7) 8.3% / 8%
Byron Donalds (R-FL-19) 91.7% / 94.2%
Alexandria Ocasio-Cortez (D-NY-14) 83.3% / 30%
James Comer (R-KY-1) 91.7% / 80%
Joaquin Castro (D-TX-20) 90.9% / 14%
In the coming weeks, Speaker Nancy Pelosi’s (D-Calif.) priority drug pricing bill, H.R. 3, is expected to come up for a vote in the House of Representatives. Make no…